Results 121 to 130 of about 2,415,366 (239)
, 2013 Meiwen Yu,1,* Kan Wu,1,* Bing Pei,2 Degang Yang,2 Qiulin Wang,1 Hongsheng Wang,1 Jianping Shen,1 Liangbing Yan,1 Guochen Zhang1 1Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for STD and ...
Wu K +8 more
core
New Phytologist, Volume 252, Issue 5, Page 2006-2023, December 2026.Schematics of ΔSPPbALE‐induced disruption of plant endomembrane trafficking impairs both preinvasive and postinvasive immunity against filamentous fungi and facilitates intracellular colonization by Plasmodiophora brassicae. Summary Plasmodiophora brassicae, an intracellular biotrophic protist that causes clubroot in crucifers, extensively alters the ...
Musharaf Hossain +4 more
wiley +1 more source
PLOS Global Public HealthZambia continues to face a high-Tuberculosis burden with rising drug resistance, yet diagnosis of non-rifampicin resistant drug-resistance remains limited due to reliance on rifampicin as a proxy for multidrug-resistant tuberculosis.
Phallon Blessing Mwaba +12 more
doaj +1 more source
Therapeutic choices in rifampicin-resistant tuberculosis [PDF]
The Lancet Infectious Diseases, 2016 Shashank, Ganatra +2 more
openaire +2 more sources
The Xpert Mycobacterium tuberculosis/rifampicin (MTB/RIF) (Cepheid, Sunnyvale, CA, US) has been pivotal in tuberculosis (TB) diagnostics, enabling the rapid detection of both TB and RIF resistance.
Caroline Victoria Choong +4 more
core +1 more source
Stimuli‐Responsive Lipid‐Based Nanocarriers for Antimicrobial Therapy
Advanced Therapeutics, Volume 9, Issue 11, November 2026.This manuscript demonstrated, through a scoping review of the literature, that modifying lipid nanocarriers with organic and inorganic excipients is a promising alternative to increase in vitro drug release of antimicrobial compounds under the studied stimulus and significantly enhance in vitro and in vivo antimicrobial activity compared to isolated ...
Brenda Maria Silva Bezerra +5 more
wiley +1 more source
Ceftriaxone‐induced liver injury: Incidence, phenotypic characterization and predictive factors
British Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3874-3885, November 2026.Introduction Ceftriaxone is a widely used third‐generation cephalosporin in hospitalized patients. Although generally considered safe, it has been associated with hepatobiliary complications and emerging reports of drug‐induced liver injury (DILI). However, data on its true incidence, phenotypic patterns, and predictors remain limited. This study aimed
Mohamed Hatem +5 more
wiley +1 more source
, 2009 In recent years, coagulase-negative staphylococci (CoNS) have been increasingly recognised as causative agents of various infections, especially in immunocompromised patients and related to implanted foreign body materials. In this study, rpoB sequencing
Hellmark, Bengt, +2 more
core +1 more source
Pharmacogenomics of dolutegravir: A scoping review of evidence, gaps and clinical implications
British Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3716-3732, November 2026.Dolutegravir underpins modern first‐ and second‐line HIV treatment regimens; however, interindividual variability in its disposition and tolerability presents challenges for optimal use. This scoping review mapped current evidence on the pharmacogenomics of dolutegravir, focusing on pharmacokinetics and pharmacodynamics, and methodological limitations ...
Ronald Kiguba +2 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 11, November 2026.Rhinoscleroma (First Case Reported from Somali). ABSTRACT Rhinoscleroma is a chronic granulomatous infection of the upper respiratory tract caused by Klebsiella rhinoscleromatis. We report, to our knowledge, the first published case from Somalia. A 60‐year‐old woman presented after two years of progressive right proptosis, nasal obstruction, and ...
Mohamed Ali Kahiye +4 more
wiley +1 more source